In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis.
William Sa JenkinsAlex T VeseyAnna VickersAnoushka NealeCatriona MolesMartin ConnellNikhil Vilas JoshiChristophe LucatelliAlison M FletcherJames C SprattSaeed MirsadraeeEdwin Jr van BeekJames H F RuddDavid E NewbyMarc R DweckPublished in: Heart (British Cardiac Society) (2019)
In vivo expression of αvβ3 integrin in human aortic atheroma is associated with plaque burden and is increased in patients with recent myocardial infarction. Quantification of αvβ3 integrin expression with 18F-fluciclatide PET has potential to assess plaque vulnerability and disease activity in atherosclerosis.
Keyphrases
- poor prognosis
- disease activity
- endothelial cells
- systemic lupus erythematosus
- left ventricular
- rheumatoid arthritis
- cardiovascular disease
- aortic valve
- heart failure
- rheumatoid arthritis patients
- binding protein
- type diabetes
- cell adhesion
- juvenile idiopathic arthritis
- positron emission tomography
- pet ct
- risk assessment
- coronary artery
- pulmonary arterial hypertension